Literature DB >> 15237855

Role of human aldehyde dehydrogenases in endobiotic and xenobiotic metabolism.

Vasilis Vasiliou1, Aglaia Pappa, Tia Estey.   

Abstract

The human genome contains at least 17 genes that are members of the aldehyde dehydrogenase (ALDH) superfamily. These genes encode NAD(P)(+)-dependent enzymes that oxidize a wide range of aldehydes to their corresponding carboxylic acids. Aldehydes are highly reactive molecules that are intermediates or products involved in a broad spectrum of physiologic, biologic, and pharmacologic processes. Aldehydes are generated during retinoic acid biosynthesis and the metabolism of amino acids, lipids, carbohydrates, and drugs. Mutations in several ALDH genes are the molecular basis of inborn errors of metabolism and contribute to environmentally induced diseases.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15237855     DOI: 10.1081/dmr-120034001

Source DB:  PubMed          Journal:  Drug Metab Rev        ISSN: 0360-2532            Impact factor:   4.518


  106 in total

1.  The enzymatic activity of human aldehyde dehydrogenases 1A2 and 2 (ALDH1A2 and ALDH2) is detected by Aldefluor, inhibited by diethylaminobenzaldehyde and has significant effects on cell proliferation and drug resistance.

Authors:  Jan S Moreb; Deniz Ucar; Shuhong Han; John K Amory; Alex S Goldstein; Blanca Ostmark; Lung-Ji Chang
Journal:  Chem Biol Interact       Date:  2011-11-03       Impact factor: 5.192

2.  Identification of low-frequency variants associated with gout and serum uric acid levels.

Authors:  Patrick Sulem; Daniel F Gudbjartsson; G Bragi Walters; Hafdis T Helgadottir; Agnar Helgason; Sigurjon A Gudjonsson; Carlo Zanon; Soren Besenbacher; Gyda Bjornsdottir; Olafur T Magnusson; Gisli Magnusson; Eirikur Hjartarson; Jona Saemundsdottir; Arnaldur Gylfason; Adalbjorg Jonasdottir; Hilma Holm; Ari Karason; Thorunn Rafnar; Hreinn Stefansson; Ole A Andreassen; Jesper H Pedersen; Allan I Pack; Marieke C H de Visser; Lambertus A Kiemeney; Arni J Geirsson; Gudmundur I Eyjolfsson; Isleifur Olafsson; Augustine Kong; Gisli Masson; Helgi Jonsson; Unnur Thorsteinsdottir; Ingileif Jonsdottir; Kari Stefansson
Journal:  Nat Genet       Date:  2011-10-09       Impact factor: 38.330

3.  Aldehyde dehydrogenase 3B1 (ALDH3B1): immunohistochemical tissue distribution and cellular-specific localization in normal and cancerous human tissues.

Authors:  Satori A Marchitti; David J Orlicky; Chad Brocker; Vasilis Vasiliou
Journal:  J Histochem Cytochem       Date:  2010-09       Impact factor: 2.479

4.  Cloning of the black seabream (Acanthopagrus schlegeli) antiquitin gene and functional characterization of its promoter region.

Authors:  Chi-Bun Chan; Wai-Kwan Tang; Christopher H K Cheng; Wing-Ping Fong
Journal:  Mol Cell Biochem       Date:  2006-10-31       Impact factor: 3.396

5.  Discovery of a series of aromatic lactones as ALDH1/2-directed inhibitors.

Authors:  Cameron D Buchman; Krishna K Mahalingan; Thomas D Hurley
Journal:  Chem Biol Interact       Date:  2015-01-29       Impact factor: 5.192

Review 6.  Fanconi anemia and the underlying causes of genomic instability.

Authors:  Julie Rageul; Hyungjin Kim
Journal:  Environ Mol Mutagen       Date:  2020-02-06       Impact factor: 3.216

7.  Inhibition of the Aldehyde Dehydrogenase 1/2 Family by Psoralen and Coumarin Derivatives.

Authors:  Cameron D Buchman; Thomas D Hurley
Journal:  J Med Chem       Date:  2017-03-06       Impact factor: 7.446

8.  Identification of 3-deoxyglucosone dehydrogenase as aldehyde dehydrogenase 1A1 (retinaldehyde dehydrogenase 1).

Authors:  François Collard; Didier Vertommen; Juliette Fortpied; Gregg Duester; Emile Van Schaftingen
Journal:  Biochimie       Date:  2006-11-24       Impact factor: 4.079

9.  Aldehyde dehydrogenase activity as a functional marker for lung cancer.

Authors:  Deniz Ucar; Christopher R Cogle; James R Zucali; Blanca Ostmark; Edward W Scott; Robert Zori; Brian A Gray; Jan S Moreb
Journal:  Chem Biol Interact       Date:  2008-10-05       Impact factor: 5.192

10.  ALDH isozymes downregulation affects cell growth, cell motility and gene expression in lung cancer cells.

Authors:  Jan S Moreb; Henry V Baker; Lung-Ji Chang; Maria Amaya; M Cecilia Lopez; Blanca Ostmark; Wayne Chou
Journal:  Mol Cancer       Date:  2008-11-24       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.